Synthesis and evaluation of a bromine-76-labeled PPARγ antagonist 2-bromo-5-nitro-N-phenylbenzamide
- 1 October 2006
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (7), 847-854
- https://doi.org/10.1016/j.nucmedbio.2006.08.003
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Selective activation of PPARγ in breast, colon, and lung cancer cell linesMolecular and Cellular Endocrinology, 2005
- An overview on biological mechanisms of PPARsPharmacological Research, 2005
- Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomesInternational Journal of Cancer, 2003
- T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular ActivitiesJournal of Biological Chemistry, 2002
- Prostaglandin D2, its metabolite 15‐d‐PGJ2, and peroxisome proliferator activated receptor‐γ agonists induce apoptosis in transformed, but not normal, human T lineage cellsImmunology, 2002
- Fluorine-Substituted Ligands for the Peroxisome Proliferator-Activated Receptor Gamma (PPARγ): Potential Imaging Agents for Metastatic TumorsBioconjugate Chemistry, 2001
- PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid CarcinomaScience, 2000
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- Production of 75Br and 77Br via the 75As(3He,3n)75Br and 75As(α,2n)77Br reactions using Cu3As-alloy as a high-current target materialThe International Journal of Applied Radiation and Isotopes, 1982